Can I abruptly stop taking trazodone (an antidepressant medication)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can You Abruptly Stop Trazodone?

No, you should not abruptly stop trazodone—gradual dose reduction is recommended to minimize withdrawal symptoms and adverse reactions. 1

FDA-Approved Discontinuation Guidance

The FDA drug label explicitly states that trazodone should be gradually reduced rather than stopped abruptly whenever possible, as adverse reactions may occur upon discontinuation. 1 This represents the highest level of regulatory guidance for this medication.

  • Gradual tapering is the standard approach: The FDA recommends reducing the dosage progressively rather than abrupt cessation to prevent discontinuation-related adverse effects. 1
  • Withdrawal symptoms can occur: Patients should be advised not to abruptly discontinue trazodone and should discuss any tapering regimen with their healthcare provider. 1

Evidence for Withdrawal Symptoms

Clinical research demonstrates that trazodone withdrawal can occur even with gradual discontinuation:

  • Documented withdrawal cases: Three published cases developed withdrawal symptoms despite gradual discontinuation of therapeutic doses, suggesting that trazodone's effects on the serotonergic system may result in noradrenergic rebound after stopping. 2
  • Mechanism of withdrawal: The short half-life of trazodone (3-9 hours) and its active metabolite m-chlorophenylpiperazine contribute to the development of withdrawal symptoms. 2, 3
  • Clinical recommendation from research: Trazodone should be tapered off at a very slow rate based on these withdrawal mechanisms. 2

Practical Tapering Approach

While specific taper schedules for trazodone are not detailed in the FDA label, general principles apply:

  • Start with dose reduction: If a patient has been on trazodone for an extended period, reduce by approximately 25-50 mg every 3-7 days, monitoring for withdrawal symptoms. 1
  • Slower tapers for long-term use: Patients on higher doses (300-600 mg/day) or those who have used trazodone for months to years may require more gradual reductions over several weeks. 1, 2
  • Monitor for discontinuation effects: Watch for rebound insomnia, anxiety, agitation, or mood changes during the taper period. 1

Common Pitfalls to Avoid

  • Don't assume benign discontinuation: Unlike some medications where abrupt cessation is safe, trazodone has documented withdrawal potential that should not be dismissed. 2
  • Avoid rapid tapers in elderly patients: Older adults may be more sensitive to discontinuation effects and require even more gradual dose reductions. 4
  • Don't stop suddenly if using for depression: Patients taking therapeutic antidepressant doses (150-400 mg/day) are at higher risk for withdrawal than those using low doses for sleep. 1, 3

Special Considerations

  • Low-dose sleep use: Even patients using trazodone at low doses (25-100 mg) for insomnia should taper gradually, though the withdrawal risk may be lower than with antidepressant doses. 4, 3
  • Rebound insomnia: Unlike benzodiazepines, trazodone does not typically cause REM rebound, but sleep disturbances can still occur with abrupt cessation. 3
  • Patient education is critical: Advise patients about the importance of not stopping trazodone on their own and the need to contact their provider if they wish to discontinue. 1

References

Research

Mechanisms of the development of trazodone withdrawal symptoms.

International clinical psychopharmacology, 1994

Research

Trazodone dosing regimen: experience with single daily administration.

The Journal of clinical psychiatry, 1990

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.